Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

Eitemau Tebyg

• A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer
  gan: Bando, Hideaki, et al.
  Cyhoeddwyd: (2019)
• Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study
  gan: Yoshino, Takayuki, et al.
  Cyhoeddwyd: (2015)
• Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study()
  gan: Taniguchi, Hiroya, et al.
  Cyhoeddwyd: (2018)
• Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients
  gan: Bando, Hideaki, et al.
  Cyhoeddwyd: (2018)
• REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer
  gan: Nakajima, Hiromichi, et al.
  Cyhoeddwyd: (2021)